Fertility information & resources

Free Open Days

Fertility Treatment FAQ's

CREATE Services FAQ's

Understanding IVF & Fertility Treatment

Glossary

Choosing An IVF Or Fertility Clinic

Scientific Papers & Academic Articles

News

Useful Addresses & Links

 
Next Free Open Day 19th May 2012 Contact CREATE Health today! Location & directions information to CREATE Health IVF Clinics Our Success Rates Blog Latest news items

CREATE NEWS

Toxic drugs used in IVF 'risk health of mothers and babies'

Professor Geeta Nargund, head of reproductive medicine at St George’s Hospital in London, said that high-dose stimulation led to side-effects, including ovarian hyper-stimulation syndrome (OHSS), a potentially fatal illness. Daily Mail 14/05/12

Read More

Women and babies 'put at risk by aggressive IVF'

Aggressive fertility treatments practised at IVF clinics in the UK are putting women and babies at risk, experts say.

Read more

IVF… Women's Health Must Come First

Lead article in the Independent 14/05/12 read article

Professor Geeta Nargund to appear on Channel 4's 4thought on Sunday 13th May 2012.

Watch the video

Professor Geeta Nargund speaks out in the Daily Mail against targeting students for donor eggs.

Fertility firm offers Cambridge University girls £750 for eggs as critics blast program for targeting 'financially vulnerable' students

Leaflets were stuck in their university pigeonholes, making an emotional plea to help a couple unable to have children. Read more

News update from the British Fertility Society

IVF linked to ovarian tumours (BBC News Online, 27 October 2011)

Researchers from The Netherlands publishing in Human Reproduction have found that ovarian stimulation, used in fertility treatments to increase the number of eggs that can be harvested, may be linked to an increased risk of developing ovarian cancer.

Full Article

The British Fertility Society has released a response to the research.

"This research shows the importance of long term follow up of patients who have fertility treatments as the impact of these therapies may not be fully appreciated or known for a considerable period of time afterwards.  The research suggests that the risk of borderline ovarian tumours is increased compared to other infertile women who do not have IVF.  However, it is essential that this increased risk is kept in perspective, as the overall risk still remains extremely small.  The cumulative life time risk for borderline ovarian cancer up to the age of 55 was 0.45% in the general population compared to 0.71% in those having IVF treatment.  The data in this study are not powerful enough to show a link between the number of cycles and this increased risk.  In the UK the HFEA has a comprehensive database of all women undergoing IVF procedures since 1991, over 300,000 treatment cycles.  Up until a recent change in legislation it was not possible due to restrictive confidentiality covenants to link the HFEA database with the UK cancer register.  However, researchers are now looking at such linkage studies which should be able to demonstrate the true risk of developing cancer after IVF treatment in the UK population.

“Screening for ovarian malignancy using ultrasound and serum markers has been shown to be effective in picking up ovarian cancer at an early stage, although there is no evidence to date that screening will actually save lives.  Moreover, screening increases the risk of surgery and operative intervention when it may not be required. 

“Clearly there needs to be a balanced approach.  Clinicians should ensure that all patients are made aware of the potential risks of ovarian stimulation and until further evidence is available, the pros and cons of future ovarian screening, to allow them to make a fully informed choice about their treatment options."

See the article on the British Fertility Society website

Geeta Nargund to speak at The Fertility Show, Olympia, London 4-5 November 2011

Treatment abroad for the reluctant traveller.
Probably the most often cited reason for going abroad for treatment is the scarcity of donor eggs in the UK. But there are risks with overseas clinics, namely that they may not necessarily be regulated to the same high standards as those in the UK and that, following treatment, one's consultant is a long way away. Create Health Clinics is one of a number of UK fertility clinics, regulated by the HFEA, who operates a scheme whereby they send patients who need donor eggs to clinics with whom they have a relationship in Cyprus but essentially retain responsibility for patient care throughout the process. CREATE's Medical Director, Geeta Nargund, explains the benefits to patients.

Book you place at this seminer

See us at the Fertility Show

You will also be able to visit us on Stand 4 where you can pick up some useful information and meet members of the team who will be on hand to answer any questions you may have.

Professor RC Chian joins the CREATE team

CREATE Health is delighted to announce that Professor RC Chian, the Pioneer of IVM and Vitrification from McGill University Canada, now directs our embryology services as Scientific Director.

Our Latest Newsletter

Icon Autumn/Winter 2011 Newsletter (404.2 KB)

Fertility and IVF in the News

We have collected the latest news articles relating to fertility and IVF in the national press.

Please click on the headlines below to read fertility related newspaper reports

Our IVF, Fertility, Antenatal, Men’s Reproductive Health, Oocyte and Support Services

Site by viedigital